http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101600425-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62a3119a692179555302c0a34599f4c8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
filingDate 2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7677418c2d50dd731c497d42ef648254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d417d14d6586b7a5dbd7c9950f6a8ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d1ae8e3c4e3a3d2a40b6cbd79f4e62
publicationDate 2009-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101600425-A
titleOfInvention Be used for the treatment of ocular hypertensive isosorbide mononitrate derivatives
abstract The present invention relates to general formula (I) chemical compound or its tautomer, the acceptable salt of medicine, prodrug or solvate and be used for preventing and/or treating purposes in preparation by the pharmaceutical composition of the ophthalmic diseases of high intraocular pressure mediation as active component.
priorityDate 2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3839223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452892474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450501848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456413165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420166489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410524311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID181458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546310

Total number of triples: 57.